Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy
Niranjan Awasthi(University of Notre Dame), Roderich E. Schwarz(Roswell Park Comprehensive Cancer Center), Florence Meyer-Losic(Ipsen (France)), Changhua Zhang(Sun Yat-sen University), Arunthathi Thiagalingam(Essen BioScience (United States)), Stephan G. Klinz(Ipsen (United States)), Margaret A. Schwarz(University of Notre Dame), Benjamin Beaufils(Ipsen (France))
Cited by 6
Related Papers
Associations of Mental Health and Personal Preventive Measure Compliance With Exposure to COVID-19 Information During Work Resumption Following the COVID-19 Outbreak in China: Cross-Sectional Survey Study
|Journal of Medical Internet Research|2020|86
Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling
|Laboratory Investigation|2008|65
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
|Liver Cancer|2023|44